Demo Sign up Log In

Biocryst Pharmaceuticals Inc (BCRX)

CapEx to Revenue

0.29%

TTM · Retrieved: Oct 22, 2026

BCRX CapEx to Revenue

Current (TTM)0.29%retrievedOct 22, 2026

Current (TTM)0.29%retrievedOct 22, 2026

BCRX CapEx/Revenue (57.14% → 0.29%)

Latest values, visible window

High-resolution chart · PNG

BCRX capex to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Biocryst Pharmaceuticals Inc CapEx to Revenue — Annual fiscal periods
Period ending	CapEx to Revenue
Dec 31, 2025	0.2821%
Dec 31, 2024	0.2494%
Dec 31, 2023	0.6542%
Dec 31, 2022	0.4988%
Dec 31, 2021	1.5175%
Dec 31, 2020	2.8857%
Dec 31, 2019	0.7024%
Dec 31, 2018	1.7721%
Dec 31, 2017	1.3023%
Dec 31, 2016	20.0243%
Dec 31, 2015	10.614%
Dec 31, 2014	0.779%
Dec 31, 2013	0.1731%
Dec 31, 2012	0.4298%
Dec 31, 2011	0.28%
Dec 31, 2010	0.5114%
Dec 31, 2009	0.8094%
Dec 31, 2008	2.1433%
Dec 31, 2007	4,693.8876%
Dec 31, 2006	24.7054%
Dec 31, 2005	327.447%
Dec 31, 2004	81.8991%
Dec 31, 2003	3.1824%
Dec 31, 2002	22.9853%
Dec 31, 2001	23.3417%
Dec 31, 2000	82.136%
Dec 31, 1999	40%
Dec 31, 1998	6.25%
Dec 31, 1997	110%
Dec 31, 1996	11.1111%
Dec 31, 1995	100%
Dec 31, 1994	57.1429%

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.